・The company said that envudeucitinib met all the primary and secondary endpoints in both trials. ・Across both trials, the company said that 74% of the patients achieved PASI 75, while 59% of them ...
PATHUM THANI, Thailand (Reuters) - Tens of thousands of Buddhist monks gathered on Friday at a Thai temple mired in controversy to join in a ceremony organisers called the world's largest offering of ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果